A widely discussed investigational peptide with a large preclinical literature but very limited human evidence. Animal studies report tissue-protective and regenerative signals; those findings have not been established as clinical benefits in women.
BPC-157 is a pentadecapeptide (15 amino acids) derived from a protective protein found in human gastric juice. It has been reported to influence angiogenesis-related pathways in preclinical models, modulates nitric oxide pathways, upregulates growth factor receptors (including VEGF, EGF, and PDGF), and counteracts lesion-induced damage across multiple organ systems including the GI tract, tendons, ligaments, muscles, and the nervous system.
IBS is 2x more common in women than men, making gut-healing peptides disproportionately relevant. A small uncontrolled pilot study in 12 women with interstitial cystitis reported large symptom improvements after a single procedure. That result is interesting but is not proof of efficacy, does not establish safety, and should not be generalized to IBS, endometriosis, surgical recovery, or other conditions.
Human safety evidence for BPC-157 is too limited to establish a reliable safety profile. Published human data are very small and do not establish common or long-term adverse-event rates. Product quality, immunogenicity, route-specific risk, and long-term safety remain uncertain.
This peptide is part of our Gut & Immune Health hub — explore all peptides for this use case.
Human safety evidence for BPC-157 is too limited to establish a reliable safety profile. A July 2026 FDA advisory committee recommended inclusion on the 503A Bulks List, but that recommendation is non-binding and is not FDA approval. However, long-term controlled trial data in women specifically is limited.
BPC-157 has preclinical GI research, but there is not adequate human evidence to conclude that it treats IBS. A small interstitial-cystitis pilot should not be extrapolated to IBS or other GI conditions.
Oral and injectable products are discussed in research and online communities, but adequate human evidence has not established a clinically optimal route for any condition. There is no validated human dosing or injection-site protocol.
Medical Disclaimer: This profile is for educational purposes only. It is not medical advice, a treatment recommendation, or a prescription guide. Always consult a licensed healthcare provider before starting any peptide therapy. Evidence ratings reflect the current state of published research and may change as new data emerges.
Affiliate Disclosure: Vendor links above are affiliate partnerships. FemPeptides may earn a commission on purchases. This does not influence our editorial content or evidence ratings. Full disclosure →
Take our 60-second quiz for a personalized recommendation based on your goals and life stage.
Find Your Peptide →